These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9420752)

  • 1. Can technetium 99m-labeled sestamibi track myocardial viability?
    Udelson JE
    J Nucl Cardiol; 1994; 1(6):571-5. PubMed ID: 9420752
    [No Abstract]   [Full Text] [Related]  

  • 2. On myocardial perfusion, metabolism, and viability.
    Hansen CL; Rastogi A; Sangrigoli R
    J Nucl Cardiol; 1998; 5(2):202-5. PubMed ID: 9588672
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.
    Duncan BH; Ahlberg AW; Levine MG; McGill CC; Mann A; White MP; Mather JF; Waters DD; Heller GV
    Am J Cardiol; 2000 Mar; 85(6):680-4. PubMed ID: 12000040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New applications of myocardial perfusion imaging.
    DePuey EG
    Tex Heart Inst J; 1996; 23(2):122-7. PubMed ID: 8792543
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake.
    Kiser JW; Drane WE; Mastin ST; Nicole MW
    Clin Nucl Med; 1998 Jul; 23(7):432-6. PubMed ID: 9676947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery.
    Sciagrà R; Bisi G; Santoro GM; Zerauschek F; Sestini S; Pedenovi P; Pappagallo R; Fazzini PF
    J Am Coll Cardiol; 1997 Aug; 30(2):384-91. PubMed ID: 9247509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of myocardial perfusion imaging to assess viability.
    Travin MI
    J Nucl Cardiol; 2000; 7(1):72-80. PubMed ID: 10698237
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium.
    Melon PG; Beanlands RS; DeGrado TR; Nguyen N; Petry NA; Schwaiger M
    J Am Coll Cardiol; 1992 Nov; 20(5):1277-83. PubMed ID: 1401632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of myocardial viability by radionuclide imaging.
    Giubbini R; Milan E; Terzi A; Pieri P
    Int J Cardiol; 1998 May; 65 Suppl 1():S65-8. PubMed ID: 9706830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy.
    Chua T; Kiat H; Germano G; Maurer G; van Train K; Friedman J; Berman D
    J Am Coll Cardiol; 1994 Apr; 23(5):1107-14. PubMed ID: 8144776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.
    Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
    Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable uptake of thallium-201 and technetium-99m MIBI in hibernating and "maimed" myocardium.
    Lipiecki J; Maublant JC; Citron B; Mestas D; Jousse F; Albuisson E; Bourgeois V; Veyre A; Ponsonnaille J
    Am J Cardiol; 1997 Oct; 80(7):940-3. PubMed ID: 9382013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201.
    Sinusas AJ; Watson DD; Cannon JM; Beller GA
    J Am Coll Cardiol; 1989 Dec; 14(7):1785-93. PubMed ID: 2584570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 201Tl and 99mTc-labeled sestamibi for assessment of myocardial viability.
    Sciagrà R; Bisi G; Santoro GM
    J Nucl Cardiol; 1996; 3(5):453-4. PubMed ID: 8902680
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of hibernated myocardium using intracoronary technetium-99m-sestamibi.
    Giordano A; Trani C; Lombardo A; Maseri A
    Q J Nucl Med; 1997 Mar; 41(1):46-50. PubMed ID: 9195853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial kinetics of radiolabeled perfusion agents: basis for perfusion imaging.
    Dahlberg ST; Leppo JA
    J Nucl Cardiol; 1994; 1(2 Pt 1):189-97. PubMed ID: 9420686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium.
    Sciagrà R; Bisi G; Santoro GM; Rossi V; Fazzini PF
    Am J Card Imaging; 1995 Jul; 9(3):157-66. PubMed ID: 7549355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 20. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.